Fragment-based drug design has emerged as an effective strategy in the pharmaceutical industry to identify small molecule fragments that bind to target proteins. Once potential fragment hits are identified, the process of optimization is essential to improve their binding affinity, selectivity, and ultimately their efficacy as drug candidates. Optimization of fragment hits is a crucial step in the drug discovery process and requires advanced computational methods and expertise. At CD ComputaBio, we offer comprehensive optimization of fragment hits services to support pharmaceutical and biotech companies in accelerating their drug discovery programs.
Fragment hit optimization is essential to improve the chemical and pharmacological properties of the initial fragment hit, without losing its binding ability to the target protein. CD ComputaBio has developed a set of services that assist in the thorough and systematic optimization of fragment hits through computational biology methods.
CD ComputaBio's optimization of fragment hits services include but are not limited to:
Our optimization of fragment hits services provides the following key features:
CD ComputaBio’s Optimization of Fragment Hits services finds wide application in drug discovery and development, agrochemical research, and molecular biology. It aids in obtaining a selective, active, and drug-like molecule from the initial fragment hit, thus, accelerating research and discovery processes. Moreover, our optimization of fragment hits services can be applied across various drug discovery projects, including:
To utilize our service, clients need to provide the target protein structure or its sequence, besides any available information on initial fragment hits. The quality of the data provided will determine the robustness and accuracy of our findings.
Our optimization of fragment hits services offers the following deliverables:
Optimization of fragment hits is a critical step in the drug discovery process, requiring sophisticated computational methods and expertise. CD ComputaBio's optimization of fragment hits services are designed to empower our clients with the tools and insights needed to drive lead compound optimization, ultimately leading to the development of novel and effective drug candidates. Leveraging our expertise in computational chemistry and molecular modeling, we are committed to supporting our clients in accelerating their drug discovery efforts and transforming fragment hits into promising lead compounds with therapeutic potential.
Reference